Additionally, multiple studies had indicated that HR status or Ki-67 index might be two important indicators for outcomes of early-stage BC [18–21], but the prognostic role HR status and Ki-67 index in HER2 nonamplified BC is also unknown. This evidence concerns the gene MKI67 and breast cancer.